CBCT碘油沉积模式预测肝癌cTACE后1年肿瘤反应
本回顾性研究纳入80例符合up-to-seven标准的221个HCC靶病灶,利用cTACE后动脉期及平扫CBCT计算肿瘤实质与碘油比值(PLR)和病灶与碘油比值(LLR),发现PLR最大值的截断值0.149是cTACE后1年肿瘤进展的独立预测因子,并在验证队列中证实其有效性。
要点
- cTACE后即刻CBCT测得肿瘤最大PLR截断值0.149可独立预测1年肿瘤进展。
- PLR和LLR的观察者间一致性接近完美(kappa>0.9)。
- 最大PLR值对应肿瘤内碘油分布最少的区域,提示后续治疗靶区。
关键影像表现/征象
- 最大PLR值指示HCC肿瘤内碘油分布最少的区域。
- 最大LLR值指示因碘油递送不完整而沉积最少的肿瘤区域。
诊断标准与关键数值
- PLR和LLR的标准截断值分别为0.149和1.4872。
- PLR和LLR截断值的观察者间一致性接近完美(kappa>0.9)。
- 多变量分析显示PLR截断值为独立预测因子(OR=1.23532×10^14,p=4.37×10^-7)。
- PLR截断值与1年进展预测模型高度一致(V=0.829-0.776;p<0.0001),验证队列中V=0.766(p<0.0001)。
临床应用与阅片要点
- cTACE后即刻CBCT可无创计算PLR和LLR,无需三维图像分析量化软件即可客观表征碘油沉积模式。
- 最大PLR值有助于早期预测肿瘤进展/复发,并指示栓塞HCC的层面,为后续cTACE或联合消融提供靶区。
- 验证队列证实了PLR和LLR的标准截断值,验证过程较既往回顾性研究更严谨。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate whether parenchyma-to-lipiodol ratio (PLR) and lesion-to-lipiodol ratio (LLR) on C-arm cone-beam computed tomography (CBCT) can predict 1-year tumor response in patients with hepatocellular carcinoma (HCC) treated with conventional transcatheter arterial chemoembolization (cTACE).
METHODS: This retrospective analysis included 221 HCC target lesions within up-to-seven criteria in 80 patients who underwent cTACE with arterial-phase CBCT and unenhanced CBCT after cTACE from 2015 to 2018. PLR and LLR of every tumor slice were obtained through mean density division of liver parenchyma and tumor enhancement with intratumoral lipiodol deposition. The cutoff values (COVs) of maximal PLR and LLR of every tumor were analyzed using Youden's index. The reliability of COV, correlations between the related parameters, and 1-year progression were assessed through interobserver agreement and multivariate analysis. COV validity was verified using the chi-square test and Cramer's V coefficient (V) in the validation cohort.
RESULTS: Standard COVs of PLR and LLR were 0.149 and 1.4872, respectively. Interobserver agreement of COV for PLR and LLR was near perfect (kappa > 0.9). Multivariate analysis suggested that COV of PLR is an independent predictor (odds ratio = 1.23532×1014, p = 4.37×10-7). COV of PLR showed strong consistency, correlation with 1-year progression in prediction model (V = 0.829-0.776; p < 0.0001), and presented as an effective predictor in the validation cohort (V = 0.766; p < 0.0001).
CONCLUSION: The COV of PLR (0.149) assessed through immediate post-embolization CBCT is an objective, effective, and approachable predictor of 1-year HCC progression after cTACE.
KEY POINTS: • The maximal PLR value indicates the least lipiodol-distributed region in an HCC tumor. The maximal LLR value indicates the least lipiodol-deposited region in the tumor due to incomplete lipiodol delivery. PLR and LLR are concepts like signal-to-noise ratio to characterize the lipiodol retention pattern objectively to predict 1-year tumor progression immediately without any quantification software for 3D image analysis immediately after cTACE treatment. • COV of PLR can facilitate the early prediction of tumor progression/recurrence and indicate the section of embolized HCC, providing the operator's good targets for sequential cTACE or combined ablation. • The validation cohort in our study verified standard COVs of PLR and LLR. The validation process was more convincing and delicate than that of previous retrospective studies.
引用
- Tsai YC, Shih JH, Hwang HE, et al. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization. Eur Radiol. 2021. PMID: 33765160. doi:10.1007/s00330-021-07843-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。